Product Name :
TA-1801
Description:
TA-1801 is a hypolipidemic agent.
CAS:
88352-44-7
Molecular Weight:
331.75
Formula:
C17H14ClNO4
Chemical Name:
ethyl 2-[2-(4-chlorophenyl)-5-(furan-2-yl)-1,3-oxazol-4-yl]acetate
Smiles :
CCOC(=O)CC1N=C(OC=1C1=CC=CO1)C1C=CC(Cl)=CC=1
InChiKey:
HUPJQAHXMFEKJY-UHFFFAOYSA-N
InChi :
InChI=1S/C17H14ClNO4/c1-2-21-15(20)10-13-16(14-4-3-9-22-14)23-17(19-13)11-5-7-12(18)8-6-11/h3-9H,2,10H2,1H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
TA-1801 is a hypolipidemic agent.|Product information|CAS Number: 88352-44-7|Molecular Weight: 331.75|Formula: C17H14ClNO4|Chemical Name: ethyl 2-[2-(4-chlorophenyl)-5-(furan-2-yl)-1,3-oxazol-4-yl]acetate|Smiles: CCOC(=O)CC1N=C(OC=1C1=CC=CO1)C1C=CC(Cl)=CC=1|InChiKey: HUPJQAHXMFEKJY-UHFFFAOYSA-N|InChi: InChI=1S/C17H14ClNO4/c1-2-21-15(20)10-13-16(14-4-3-9-22-14)23-17(19-13)11-5-7-12(18)8-6-11/h3-9H,2,10H2,1H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Etrasimod} web|{Etrasimod} LPL Receptor|{Etrasimod} Biological Activity|{Etrasimod} Description|{Etrasimod} custom synthesis|{Etrasimod} Cancer} |Shelf Life: ≥12 months if stored properly.{{CHAPS} site|{CHAPS} Protocol|{CHAPS} Formula|{CHAPS} supplier|{CHAPS} Autophagy} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:23756629 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|TA-1801 inhibits platelet aggregation in vitro.|In Vivo:|TA-1801 reduces serum cholesterol and triglyceride levels by 23% and 35%, respectively, at a dose of 0.05% in a diet in normal rats, and it is about 10 times more active in hereditary hyperlipidemic rats (THLR/1) than in normal rats.|Products are for research use only. Not for human use.|
